Intravenous immunoglobulin (IVIG) treatment of experimental colitis induced by dextran sulfate sodium in rats

Clinical and Experimental Immunology

Volumn 108, Issue 2, 1997, Pages 340-345

  Shintani, N ^a   Nakajima, T ^a   Nakakubo, H ^a   Nagai, H ^a   Kagitani, Y ^a   Takizawa, H ^b   Asakura, H ^b  

^a Green Cross Company   (South Korea)

^b NIIGATA UNIVERSITY   (Japan)

Author keywords

cytokines; dextran sulfate; immunocompetent cells; immunoglobulin; ulcerative colitis

Indexed keywords

ALBUMIN; CYTOKINE; DEXTRAN SULFATE; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; INTERLEUKIN 1ALPHA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLON MUCOSA; CONTROLLED STUDY; DRUG MECHANISM; IMMUNOCOMPETENT CELL; IMMUNOTHERAPY; INTRAVENOUS DRUG ADMINISTRATION; LAMINA PROPRIA; MACROPHAGE; MALE; NONHUMAN; OCCULT BLOOD; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; T LYMPHOCYTE; ULCERATIVE COLITIS;

EID: 0030997860     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1997.d01-1021.x     Document Type: Article

References (28)

1. Imbach P, d'Apuzzo V, Hirt A et al. High-dose intravenous gamma-globulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1981; 1:1228-30.
2. Jordan SC. Intravenous gamma-globulin therapy in systemic lupus erythematosus and immune complex disease. Clin Immunol Immunopathol 1989; 53:S164-9.
3. Bussel JB, Cunningham-Rundles C, Abraham C. Intravenous treatment of autoimmune hemolytic anemia with very high dose gammaglobulin. Vox Sang 1986; 51:264-9.
4. Arsura E. Experience with intravenous immunoglobulin in myasthenia gravis. Clin Immunol Immunopathol 1989; 53:5170-9.
5. Furusho K, Kamiya T, Nakano H et al. High-dose intravenous gamma-globulin for Kawasaki disease. Lancet 1984; 2:1055-8.
6. Cottier H, Hassig A. Immunoglobulin in chronic inflammatory diseases. Vox Sang 1986; 51 (Suppl. 2):39-43.
7. Rohr G, Kusterer K, Schule M et al. Treatment of Crohn's disease and ulcerative colitis with 7S-immunoglobulin. Lancet 1987; 1:170.
8. Levine DS, Fischer SH, Christie DL et al. Intravenous immunoglobulin therapy for active, extensive, and medically refractory idiopathic ulcerative or Crohn's colitis. Am J Gastroenterol 1992; 87:91-100.
9. Ohkusa T. Production of experimental ulcerative colitis in hamsters by dextran sulfate sodium and changes in intestinal microflora. Jpn J Gastroenterol 1985; 82:1327-36.
10. Okayasu I, Hatakeyama S, Yamada M et al. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990; 98:694-702.
11. Takizawa H, Sasakawa T, Nakazawa T et al. Dynamics of immunocompetent cells in colitis mucosa induced by dextran sulfate in rats. In: Tsuchiya M, Nagura H, Hibi T, Mori I, eds. Frontiers of mucosal immunology. Amsterdam: Excerpta Medica, 1991:853-4.
12. MacDonald TT, Hutchings P, Choy MY et al. Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine. Clin Exp Immunol 1990; 81:301-5.
13. Murch SH, Lamkin VA, Savage MO et al. Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease. Gut 1991; 32:913-7.
14. Braegger CP, Nicholls S, Murch SH et al. Tumour necrosis factor alpha in stool as a marker of intestinal inflammation. Lancet 1992; 339:89-91.
15. Mahida YR, Wu K, Jewell DP. Enhanced production of interleukin-1 beta by mononuclear cells isolated from mucosa with active ulcerative colitis or Crohn's disease. Gut 1989; 30:835-8.
16. Cohn EG, Strong LE, Hughes WL et al. Preparation and properties of serum and plasma proteins IV. A system for the separation into fractions of the protein and lipoprotein components of biological tissues and fluids. J Am Chem Soc 1946; 68:459-75.
17. Oncley JL, Melin M, Richert DA et al. The separation of the antibodies, isoagglutinins, prothrombin, plasminogen and b1-lipoprotein into subfractions of human plasma. J Am Chem Soc 1949; 71:541-50.
18. Takizawa H, Shintani N, Natsui M et al. Activated immunocompetent cells in rat colitis mucosa induced by dextran sulfate sodium and not complete but partial suppression of colitis by FK506. Digestion 1995; 56:259-64.
19. Davies MD J, Parrott DMV. Preparation and purification of lymphocytes from the epithelium and lamina propria of murine small intestine. Gut 1981; 22:481-8.
20. Nauss KM, Pavlina TM, Kumar V et al. Functional characteristics of lymphocytes isolated from the rat large intestine. Gastroenterology 1984; 86:468-75.
21. Ramsay AJ, Holmes MJ. A rabbit model for mucosal immunity in the bowel. II Local cellular reactivity to virus infection. Immunology 1990; 69:27-32.
22. Kramer SM, Carver ME. Serum-free in vitro bioassay for the detection of tumor necrosis factor. J Immunol Methods 1986; 93:201-6.
23. Kaveri SV, Dietrich G, Hurez V et al. Intravenous immunoglobulins (IVIg) in the treatment of autoimmune diseases. Clin Exp Immunol 1991; 86:192-8.
24. Andersson JP, Andersson UG. Human intravenous immunoglobulin modulates monokine production in vitro. Immunology 1990; 71:372-6.
25. Andersson UG, Björk L, Skansén-Saphir U et al. Down-regulation of cytokine production and interleukin-2 receptor expression by pooled human IgG. Immunology 1993; 79:211-6.
26. Skansén-Saphir U, Andersson J, Björk L et al. Lymphokine production induced by streptococcal pyrogenic exotoxin-A is selectively down-regulated by pooled human IgG. Eur J Immunol 1994; 24:916-22.
27. Iwata M, Shimozato T, Tokiwa H et al. Antipyretic activity of a human immunoglobulin preparation for intravenous use in an experimental model of fever in rabbits. Infect Immun 1987; 55:547-54.
28. Shimozato T, Iwata M, Tamura N et al. Suppression of tumor necrosis factor alpha production by a human immunoglobulin preparation for intravenous use. Infect Immun 1990; 58:1384-90.